Reviva Pharmaceuticals Holdings, Inc. (RVPH): SCHEDULE 13G filed Mar 25, 2026

Name: Reviva Pharmaceuticals Holdings, Inc. SCHEDULE 13G (0001649553-26-000036)
Creator: Reviva Pharmaceuticals Holdings, Inc.
Published: 2026-03-25

Form type: SCHEDULE 13G
Filing date: Mar 25, 2026
Accession number: 0001649553-26-000036
Filer: Reviva Pharmaceuticals Holdings, Inc. (CIK 1742927)